Prognostic model development using novel genetic signature associated with adenosine metabolism and immune status for patients with hepatocellular carcinoma
Journal of Physiology and Biochemistry · 2025
DOI: 10.1007/s13105-024-01061-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Physiology and Biochemistry, 2025. Verfasst von Yidan Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Xijing Hospital, Air Force Medical University, Xi…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Adenosine, Biomarkers, Tumor. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key Research and Development Projects of Shaanxi Province, Science and Technology Innovation team of Shaanxi Province.
Abstract (Originalsprache)
The high mortality rate of hepatocellular carcinoma (HCC) is partly due to advanced diagnosis, emphasizing the need for effective predictive tools in HCC treatment. The aim of this study is to propose a novel prognostic model for HCC based on adenosine metabolizing genes and explore the potential relationship between them. Regression analysis was performed to identify differentially expressed genes associated with adenosine metabolism in HCC patients using RNA sequencing data obtained from a public database. Adenosine metabolism-related risk score (AMrisk) was derived using the least absolute shrinkage and selection operator (LASSO) Cox regression and verified using another database. Changes in adenosine metabolism in HCC were analyzed using functional enrichment analysis and multiple immune scores. The gene expression levels in patient samples were validated using quantitative reverse transcription polymerase chain reaction. Thirty adenosine metabolism-related differentially expressed genes were identified in HCC, and six genes (ADA, P2RY4, P2RY6, RPIA, SLC6A3, and VEGFA) were used to calculate the AMrisk score; the higher the risk scores, the lower the overall survival. Moreover, immune infiltration activation and immune checkpoints were considerably higher in the high-risk group. Additional in vitro experiments validated the enhanced expression of these six genes in HCC. The established predictive model demonstrated that adenosine metabolism-related genes was significantly associated with prognosis in HCC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Xijing Hospital, Air Force Medical University, Xi'an, China.
- School of Basic Medicine, Air Force Medical University, Xi'an, China.
- Department of General Medicine, Xijing Hospital, Air Force Medical University, Xi'an, China.
- Department of Pediatric, Xijing Hospital, Air Force Medical University, Xi'an, China.
- Department of Gastroenterology, Dongying People's Hospital, Dongying, China. 13792081898@163.com.
- National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Xijing Hospital, Air Force Medical University, Xi'an, China. 13669287592@163.com.
Förderung
- National Natural Science Foundation of China
- Key Research and Development Projects of Shaanxi Province
- Science and Technology Innovation team of Shaanxi Province
Zitieren
APA
Chen, Y., Wang, K., Zhang, X., Tao, D., Shang, Y., Wang, P., Li, Q., & Liu, Y. (2025). Prognostic model development using novel genetic signature associated with adenosine metabolism and immune status for patients with hepatocellular carcinoma. Journal of Physiology and Biochemistry. https://doi.org/10.1007/s13105-024-01061-8
Vancouver
Chen Y, Wang K, Zhang X, Tao D, Shang Y, Wang P, et al. Prognostic model development using novel genetic signature associated with adenosine metabolism and immune status for patients with hepatocellular carcinoma. Journal of Physiology and Biochemistry. 2025. doi:10.1007/s13105-024-01061-8
BibTeX
@article{Chen2025,
author = {Chen, Yidan and Wang, Kemei and Zhang, Xingyun and Tao, Dongying and Shang, Yulong and Wang, Ping and Li, Qiang and Liu, Yansheng},
title = {Prognostic model development using novel genetic signature associated with adenosine metabolism and immune status for patients with hepatocellular carcinoma},
journal = {Journal of Physiology and Biochemistry},
year = {2025},
doi = {10.1007/s13105-024-01061-8}
}
EUVIMED